Author Correction: An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients

被引:0
|
作者
Rajan Ravichandran
Surapaneni Krishna Mohan
Suresh Kumar Sukumaran
Devakumar Kamaraj
Sumetha Suga Daivasuga
Samson Oliver Abraham Samuel Ravi
Sivakumar Vijayaraghavalu
Ramarathnam Krishna Kumar
机构
[1] MIOT International,Department of Nephrology
[2] Indian Institute of Technology Madras (IITM),Adjunct Faculty
[3] Panimalar Medical College Hospital and Research Institute,Departments of Biochemistry, Molecular Virology and Research
[4] Panimalar Medical College Hospital and Research Institute,Department of General Medicine
[5] Panimalar Medical College Hospital and Research Institute,Departments of Pharmacology and Research
[6] Panimalar Medical College Hospital and Research Institute,Departments of Microbiology and Molecular Virology
[7] Molbio Diagnostics Private Limited,School of Life Sciences
[8] Manipur University,Department of Engineering Design
[9] IITM,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Efficacy of clarithromycin in patients with mild COVID-19 pneumonia patients: An exploratory, multicenter, open-label, randomized controlled trial
    Yamamoto, Kazuko
    Fukuda, Yuichi
    Sawai, Toyomitsu
    Ide, Shotaro
    Mori, Yusuke
    Hashiguchi, Kohji
    Ishii, Hiroshi
    Futsuki, Yoji
    Iwanaga, Naoki
    Hosogaya, Naoki
    Sakamoto, Noriho
    Yoshida, Haruo
    Takamatsu, Yuki
    Ota, Kenji
    Izumikawa, Koichi
    Yanagihara, Katsunori
    Mukae, Hiroshi
    RESPIROLOGY, 2023, 28 : 226 - 226
  • [22] Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)
    Gyselinck, Iwein
    Liesenborghs, Laurens
    Belmans, Ann
    Engelen, Matthias M.
    Betrains, Albrecht
    Quentin Van Thillo
    Pham Anh Hong Nguyen
    Goeminne, Pieter
    Soenen, Ann-Catherine
    De Maeyer, Nikolaas
    Pilette, Charles
    Papleux, Emmanuelle
    Vanderhelst, Eef
    Derweduwen, Aurelie
    Alexander, Patrick
    Bouckaert, Bernard
    Martinot, Jean-Benoit
    Decoster, Lynn
    Vandeurzen, Kurt
    Schildermans, Rob
    Verhamme, Peter
    Janssens, Wim
    Vos, Robin
    ERJ OPEN RESEARCH, 2022, 8 (01)
  • [23] Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial
    Darazam, Ilad Alavi
    Shokouhi, Shervin
    Mardani, Masoud
    Pourhoseingholi, Mohamad Amin
    Rabiei, Mohammad Mahdi
    Hatami, Firouze
    Shabani, Minoosh
    Moradi, Omid
    Gharehbagh, Farid Javandoust
    Irvani, Seyed Sina Naghibi
    Amirdosara, Mahdi
    Hajiesmaeili, Mohammadreza
    Rezaei, Omidvar
    Khoshkar, Ali
    Lotfollahi, Legha
    Gachkar, Latif
    Dehbsneh, Hadiseh Shabanpour
    Khalili, Negar
    Soleymaninia, Azam
    Kusha, Akram Hoseyni
    Shoushtari, Maryam Taleb
    Torabinavid, Parham
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99
  • [24] A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia
    Avendano-Sola, Cristina
    Ramos-Martinez, Antonio
    Munez-Rubio, Elena
    Ruiz-Antoran, Belen
    Malo de Molina, Rosa
    Torres, Ferran
    Fernandez-Cruz, Ana
    Calderon-Parra, Jorge
    Payares-Herrera, Concepcion
    Diaz de Santiago, Alberto
    Romera-Martinez, Irene
    Pintos, Ilduara
    Lora-Tamayo, Jaime
    Mancheno-Losa, Mikel
    Paciello, Maria L.
    Martinez-Gonzalez, A. L.
    Vidan-Estevez, Julia
    Nunez-Orantos, Maria J.
    Isabel Saez-Serrano, Maria
    Porras-Leal, Maria L.
    Jarilla-Fernandez, Maria C.
    Villares, Paula
    Perez de Oteyza, Jaime
    Ramos-Garrido, Ascension
    Blanco, Lydia
    Madrigal-Sanchez, Maria E.
    Rubio-Batlles, Martin
    Velasco-Iglesias, Ana
    Pano-Pardo, Jose R.
    Moreno-Chulilla, J. A.
    Muniz-Diaz, Eduardo
    Casas-Flecha, Inmaculada
    Perez-Olmeda, Mayte
    Garcia-Perez, Javier
    Alcami, Jose
    Bueno, Jose L.
    Duarte, Rafael F.
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (20):
  • [25] A Randomized, Open-Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID-19, a Pilot Study
    Ren, Zhigang
    Luo, Hong
    Yu, Zujiang
    Song, Jingchao
    Liang, Lan
    Wang, Ling
    Wang, Haiyu
    Cui, Guangying
    Liu, Yong
    Wang, Jin
    Li, Qingquan
    Zeng, Zhaohai
    Yang, Shengkun
    Pei, Guangzhong
    Zhu, Yonghui
    Song, Wenbin
    Yu, Wenquan
    Song, Chuanjun
    Dong, Lihong
    Hu, Chuansong
    Du, Jinfa
    Chang, Junbiao
    ADVANCED SCIENCE, 2020, 7 (19)
  • [26] Inhaled ciclesonide in adults hospitalised with COVID-19: a randomised controlled open-label trial (HALT COVID-19)
    Brodin, Daniel
    Tornhammar, Per
    Ueda, Peter
    Krifors, Anders
    Westerlund, Eli
    Athlin, Simon
    Wojt, Sandra
    Elvstam, Olof
    Neumann, Anca
    Elshani, Arsim
    Giesecke, Julia
    Edvardsson-Kallkvist, Jens
    Bunpuckdee, Sayam
    Unge, Christian
    Larsson, Martin
    Johansson, Bjoern
    Ljungberg, Johan
    Lindell, Jonas
    Hansson, Johan
    Blennow, Ola
    Andersson, Daniel Peter
    BMJ OPEN, 2023, 13 (03):
  • [27] Inhaled ciclesonide in adults hospitalised with COVID-19: a randomised controlled open-label trial (HALT COVID-19)
    Brodin, Daniel
    Tornhammar, Per
    Ueda, Peter
    Krifors, Anders
    Westerlund, Eli
    Athlin, Simon
    Wojt, Sandra
    Elvstam, Olof
    Neumann, Anca
    Elshani, Arsim
    Giesecke, Julia
    Edvardsson-Kallkvist, Jens
    Bunpuckdee, Sayam
    Unge, Christian
    Larsson, Martin
    Johansson, Bjorn
    Ljungberg, Johan
    Lindell, Jonas
    Hansson, Johan
    Blennow, Ola
    Andersson, Daniel Peter
    BMJ OPEN, 2023, 13 (02):
  • [28] Efficacy of Quinine Sulfate in Patients with Mild-To-Moderate COVID-19: A Randomized Controlled Trial
    Latarissa, Irma Rahayu
    Barliana, Melisa Intan
    Meiliana, Anna
    Sormin, Ida Paulina
    Sugiono, Erizal
    Kartasasmita, Cissy Bana
    Irmansyah
    Lestari, Keri
    INDONESIAN BIOMEDICAL JOURNAL, 2023, 15 (06): : 366 - 374
  • [29] AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India
    Singh, Harbans
    Srivastava, Sumit
    Yadav, Babita
    Rai, Amit K.
    Jameela, Sophia
    Muralidharan, Sanuj
    Mohan, Rijin
    Chaudhary, Shikha
    Singhal, Richa
    Rana, Rakesh
    Khanduri, Shruti
    Sharma, Bhagwan S.
    Chandrasekhararao, Bhogavalli
    Srikanth, Narayanam
    Chaturvedi, Sarika
    COMPLEMENTARY THERAPIES IN MEDICINE, 2022, 66
  • [30] Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial
    Gottlieb, Robert L.
    Nirula, Ajay
    Chen, Peter
    Boscia, Joseph
    Heller, Barry
    Morris, Jason
    Huhn, Gregory
    Cardona, Jose
    Mocherla, Bharat
    Stosor, Valentina
    Shawa, Imad
    Kumar, Princy
    Adams, Andrew C.
    Van Naarden, Jacob
    Custer, Kenneth L.
    Durante, Michael
    Oakley, Gerard
    Schade, Andrew E.
    Holzer, Timothy R.
    Ebert, Philip J.
    Higgs, Richard E.
    Kallewaard, Nicole L.
    Sabo, Janelle
    Patel, Dipak R.
    Klekotka, Paul
    Shen, Lei
    Skovronsky, Daniel M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (07): : 632 - 644